How to Buy Indraprastha Medical Corporation Ltd Shares?
You can easily buy the stocks/shares of Indraprastha Medical Corporation Ltd (INDRAMEDCO) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Indraprastha Medical Corporation Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of INDRAMEDCO as on 15th May 2025 is ₹414.23What is the return on Indraprastha Medical Corporation Ltd share?
The past returns of Indraprastha Medical Corporation Ltd (INDRAMEDCO) share are- Past 1 week: N/A
- Past 1 month: -87.11
- Past 3 months: 29.45
- Past 6 months: -14.91
- Past 1 year: 63.14
- Past 3 years: 617.03
- Past 5 years: 939.06
What is the Dividend yield % on Indraprastha Medical Corporation Ltd share?
The current dividend yield of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is 1.10What is the Market Cap of Indraprastha Medical Corporation Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹3738.52Cr as of 15th May 2025What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?
The 52-week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹572 and ₹232.50.What is the PE and PB ratio of Indraprastha Medical Corporation Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Indraprastha Medical Corporation Ltd are 23.22 and 7.83 respectively.Which sector does Indraprastha Medical Corporation Ltd belong to?
Indraprastha Medical Corporation Ltd (INDRAMEDCO) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.What are the peers or stocks similar to Indraprastha Medical Corporation Ltd?
The peers or stocks similar to Indraprastha Medical Corporation Ltd are: and many others.Can't decide whether or not to buy Indraprastha Medical Corporation Ltd?
Worry no more! Login to Tickertape and check out Indraprastha Medical Corporation Ltd (INDRAMEDCO) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Indraprastha Medical Corporation Ltd?
The 52-week high and low of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹572 and ₹232.50.1. Test Stocks FAQ for Indraprastha Medical Corporation Ltd Shares?
You can easily buy the stocks/shares of Indraprastha Medical Corporation Ltd (INDRAMEDCO) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Indraprastha Medical Corporation Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of INDRAMEDCO as on 15th May 2025 is ₹414.23
Indraprastha Medical Corporation Ltd
INDRAMEDCO Share Price
414.231.23% (+5.03)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
INDRAMEDCO Performance & Key Metrics
INDRAMEDCO Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.22 | 7.83 | 1.10% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.21 | 6.66 | 0.83% |
INDRAMEDCO Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
INDRAMEDCO Company Profile
Indraprastha Medical Corporation Limited is engaged in healthcare business.
MAXHEALTH
PE Ratio
111.25
111.25
1Y Return
38.51%
38.51%
Buy Reco %
100.00
100.00
APOLLOHOSP
PE Ratio
69.46
69.46
1Y Return
12.70%
12.70%
Buy Reco %
100.00
100.00
FORTIS
PE Ratio
73.43
73.43
1Y Return
56.11%
56.11%
Buy Reco %
100.00
100.00
PE Ratio
49.11
49.11
1Y Return
55.97%
55.97%
Buy Reco %
87.50
87.50
MEDANTA
PE Ratio
66.10
66.10
1Y Return
7.16%
7.16%
Buy Reco %
—
—
INDRAMEDCO Sentiment Analysis
INDRAMEDCO Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
INDRAMEDCO Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
INDRAMEDCO Stock Growth Drivers
INDRAMEDCO Stock Growth Drivers
1Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
INDRAMEDCO Stock Challenges
INDRAMEDCO Stock Challenges
2Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
INDRAMEDCO Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
INDRAMEDCO Forecasts
Price
Revenue
Earnings
INDRAMEDCO Share Price Forecast
INDRAMEDCO Share Price Forecast
2025
Current
₹408.35
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹408.35
Baseline
Forecast for Jun 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO Company Revenue Forecast
INDRAMEDCO Company Revenue Forecast
2025
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.38
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
INDRAMEDCO Stock EPS (Earnings Per Share) Forecast
2025
Current
₹17.56
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹17.56
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
INDRAMEDCO
INDRAMEDCO
Income
Balance Sheet
Cash Flow
Annual Normal View
INDRAMEDCO Income Statement
INDRAMEDCO Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 766.18 | 753.45 | 788.64 | 831.46 | 614.06 | 891.28 | 1,108.70 | 1,261.59 | 1,379.01 | 1,379.01 | ||||||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,112.09 | 1,112.09 | ||||||||||
| Power & Fuel Cost | 20.91 | 19.26 | 19.70 | 21.16 | 17.18 | 20.56 | 22.74 | 26.01 | ||||||||||||
| Employee Cost | 190.26 | 194.01 | 200.21 | 213.93 | 197.71 | 213.92 | 246.70 | 261.61 | ||||||||||||
| Selling & Administrative Expenses | 76.58 | 72.29 | 78.20 | 83.66 | 186.62 | 292.12 | 407.26 | 462.43 | ||||||||||||
| Operating & Other expenses | 399.17 | 394.31 | 409.28 | 425.63 | 171.60 | 247.26 | 271.27 | 301.29 | ||||||||||||
EBITDA | 79.26 | 73.58 | 81.25 | 87.08 | 40.95 | 117.42 | 160.73 | 210.25 | 266.92 | 266.92 | ||||||||||
| Depreciation/Amortization | 30.53 | 30.68 | 29.75 | 32.97 | 33.32 | 34.94 | 39.27 | 40.08 | 44.33 | 44.33 | ||||||||||
| PBIT | 48.73 | 42.90 | 51.50 | 54.11 | 7.63 | 82.48 | 121.46 | 170.17 | 222.59 | 222.59 | ||||||||||
| Interest & Other Items | 7.91 | 8.90 | 6.87 | 5.92 | 3.34 | 3.41 | 4.28 | 4.06 | 6.27 | 6.27 | ||||||||||
| PBT | 40.82 | 34.00 | 44.63 | 48.19 | 4.29 | 79.07 | 117.18 | 166.11 | 216.32 | 216.32 | ||||||||||
| Taxes & Other Items | 14.57 | 12.90 | 16.21 | 4.57 | 1.96 | 20.45 | 31.03 | 42.15 | 55.33 | 55.33 | ||||||||||
| Net Income | 26.25 | 21.10 | 28.42 | 43.62 | 2.33 | 58.62 | 86.15 | 123.96 | 160.99 | 160.99 | ||||||||||
| EPS | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 17.56 | ||||||||||
| DPS | 1.80 | 1.50 | 1.60 | 0.00 | 0.00 | 2.50 | 3.00 | 4.50 | 4.50 | 4.50 | ||||||||||
| Payout ratio | 0.63 | 0.65 | 0.52 | 0.00 | 0.00 | 0.39 | 0.32 | 0.33 | 0.26 | 0.26 |
INDRAMEDCO Company Updates
INDRAMEDCO Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
INDRAMEDCO Past Performance & Peer Comparison
INDRAMEDCO Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation-basic on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indraprastha Medical Corporation Ltd | 23.22 | 7.83 | 1.10% |
| Max Healthcare Institute Ltd | 111.25 | 14.23 | 0.12% |
| Apollo Hospitals Enterprise Ltd | 69.46 | 13.72 | 0.40% |
| Fortis Healthcare Ltd | 73.43 | 6.64 | 0.13% |
INDRAMEDCO Stock Price Comparison
Compare INDRAMEDCO with any stock or ETFCompare INDRAMEDCO with any stock or ETF
INDRAMEDCO
INDRAMEDCO Holdings
INDRAMEDCO Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
INDRAMEDCO Promoter Holdings Trend
INDRAMEDCO Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
INDRAMEDCO Institutional Holdings Trend
INDRAMEDCO Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding Pattern
INDRAMEDCO Shareholding History
INDRAMEDCO Shareholding History
Foreign Institutions
Mutual Funds Invested in INDRAMEDCO
Mutual Funds Invested in INDRAMEDCO
No mutual funds holding trends are available
Top 2 Mutual Funds holding Indraprastha Medical Corporation Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.4043% | Percentage of the fund’s portfolio invested in the stock 0.20% | Change in the portfolio weight of the stock over the last 3 months 0.20% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 116/118 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0007% | Percentage of the fund’s portfolio invested in the stock 0.14% | Change in the portfolio weight of the stock over the last 3 months 0.14% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 63/102 (-36) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing INDRAMEDCO stock
smallcases containing INDRAMEDCO stock
Looks like this stock is not in any smallcase yet.
INDRAMEDCO Events
INDRAMEDCO Events
INDRAMEDCO Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
INDRAMEDCO Dividend Trend
No dividend trend available
INDRAMEDCO Upcoming Dividends
INDRAMEDCO Upcoming Dividends
No upcoming dividends are available
INDRAMEDCO Past Dividends
INDRAMEDCO Past Dividends
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹4.50
Dividend/Share
₹4.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 14, 2023
Final
Final | Div/Share: ₹3.00
Dividend/Share
₹3.00
Ex DateEx Date
Sep 14, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
Cash Dividend
Ex DateEx DateSep 12, 2019
Final
Final | Div/Share: ₹1.60
Dividend/Share
₹1.60
Ex DateEx Date
Sep 12, 2019
Cash Dividend
Ex DateEx DateSep 12, 2018
Final
Final | Div/Share: ₹1.50
Dividend/Share
₹1.50
Ex DateEx Date
Sep 12, 2018
INDRAMEDCO Stock News & Opinions
INDRAMEDCO Stock News & Opinions
Articles & Videos
Corporate
Indraprastha Medical Corporation announces cessation of director
Indraprastha Medical Corporation announced that Dr. Menaka Guruswamy (DIN 08742679) has completed her tenure viz. first term of five (5) consecutive years on 22 May 2025, as Independent Director on the Board of Directors of the Company. Owing to her professional commitments & law practice as a Senior Advocate at the Supreme Court of India, she has opted not to renew her second term as an Independent Director on the Board of Directors of the Company. Consequently, she cease to be the Independent Director of the CompanyPowered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Board of Indraprastha Medical Corporation recommends final dividend
Indraprastha Medical Corporation announced that the Board of Directors of the Company at its meeting held on 16 May 2025, inter alia, have recommended the final dividend of Rs 4.5 per equity Share (i.e. 45%) , subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 31.57% in the March 2025 quarter
Net profit of Indraprastha Medical Corporation rose 31.57% to Rs 41.01 crore in the quarter ended March 2025 as against Rs 31.17 crore during the previous quarter ended March 2024. Sales rose 6.04% to Rs 333.75 crore in the quarter ended March 2025 as against Rs 314.73 crore during the previous quarter ended March 2024. For the full year,net profit rose 29.87% to Rs 160.99 crore in the year ended March 2025 as against Rs 123.96 crore during the previous year ended March 2024. Sales rose 8.97% to Rs 1356.36 crore in the year ended March 2025 as against Rs 1244.70 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales333.75314.73 6 1356.361244.70 9 OPM %18.3715.39 -18.0115.53 - PBDT66.1851.77 28 260.65206.19 26 PBT55.2741.56 33 216.32166.11 30 NP41.0131.17 32 160.99123.96 30 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to discuss results
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Spotlight
ICRA reaffirms ratings of Indraprastha Medical Corp; maintains 'stable' outlook
The agency has also affirmed the company's short term rating at '[ICRA] A1+'. ICRA stated that the rating action factors in Indraprastha Medical Corporation Limited (IMCL)'s established presence and strong market position in the NCR region, its healthy operating metrics and its robust financial profile. The ratings also factor in IMCL's revenue diversification across specialities, including oncology, neurology, cardiology and nephrology, among others. The financial risk profile remains comfortable as reflected by minimal gearing, robust debt protection indicators and a strong liquidity profile. Further, the ratings factor in the strong parentage of Apollo Hospitals Enterprise Limited (AHEL) along with its promoters, holding a 25% stake in IMCL. The entity has significant operational, financial and managerial linkages with AHEL. Apollo Hospitals is among the leading healthcare players, operating one of the largest hospital chains in the country. However, the ratings remain constrained by the geographical and asset concentration risks, as IMCL's operations are concentrated across two hospitals in the National Capital Region (NCR). Like other entities in the sector, IMCL remains exposed to regulatory risks, with previous restrictions imposed by various authorities. The ratings also factor in the competitive pressures and the necessity to retain medical talent in an ever-evolving market. Incorporated in 1988 as a JV between Apollo Hospitals Enterprise (AHEL) and the Delhi Government, Indraprastha Medical Corporation (IMCL) is a 749-bedded, super speciality tertiary care hospital in New Delhi and Noida. The scrip gained 3.09% to currently trade at Rs 415.30 on the BSE. Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to conduct board meeting
Indraprastha Medical Corporation will hold a meeting of the Board of Directors of the Company on 3 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Indraprastha Medical Corporation standalone net profit rises 29.07% in the September 2024 quarter
Net profit of Indraprastha Medical Corporation rose 29.07% to Rs 42.40 crore in the quarter ended September 2024 as against Rs 32.85 crore during the previous quarter ended September 2023. Sales rose 10.35% to Rs 349.82 crore in the quarter ended September 2024 as against Rs 317.00 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales349.82317.00 10 OPM %18.1915.89 - PBDT68.1053.68 27 PBT56.9343.65 30 NP42.4032.85 29 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Indraprastha Medical Corporation to hold AGM
Indraprastha Medical Corporation announced that the 36th Annual General Meeting (AGM) of the company will be held on 24 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Indraprastha Medical Corporation standalone net profit rises 46.79% in the June 2024 quarter
10 months agoBusiness Standard
Earnings
Indraprastha Medical Corporation standalone net profit rises 46.79% in the June 2024 quarter
Net profit of Indraprastha Medical Corporation rose 46.79% to Rs 44.77 crore in the quarter ended June 2024 as against Rs 30.50 crore during the previous quarter ended June 2023. Sales rose 13.49% to Rs 347.86 crore in the quarter ended June 2024 as against Rs 306.51 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales347.86306.51 13 OPM %19.3015.42 - PBDT70.6350.04 41 PBT59.5940.23 48 NP44.7730.50 47 Powered by Capital Market - Live
10 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.85%, vs industry avg of 10.01%
Over the last 5 years, market share decreased from 2.15% to 1.98%
Over the last 5 years, net income has grown at a yearly rate of 34.26%, vs industry avg of 42.91%